Advocacy Actions

2021-06-03 > All chapters

Closed-door online briefing session on the European Commission’s initiative on an anti-coercion mechanism

On 3rd June the European Chamber invited Mr Colin Brown, Head of Unit, Legal Affairs/Dispute settlement at the European Commission, to brief key members on the Commission's initiative on an instrument to deter and prevent coercive actions by non-EU countries.

Read more
2021-06-03 > Beijing, Shanghai

Submitted comments on PBOC's Uniform Registration Measures for Moving Property and Rights Guarantees (Revised Draft for Comments)

The draft Measures are implementation measures of the People's Republic of China's Civil Code. Among other things, the NBFI WG suggested that registration of vehicles should be included in these Measures.

Read more
2021-06-02 > Beijing, Shanghai

Meeting with Radio Regulation Bureau under the Ministry of Industry and Information Technology (MIIT) on the Radio Regulation of Automotive Radar

Meeting with Radio Regulation Bureau under the Ministry of Industry and Information Technology (MIIT) on the released draft for public consultation on Interim Provisions on Radio Regulation of Automotive Radar.

Read more
2021-06-02 > Beijing, Shanghai

EU-China Intellectual Property Working Group Industry Session Meeting

The EU-China Intellectual Property Working Group Industry Session meeting was held on 2 June.

Read more
2021-05-31 > Beijing

Conclusion Meeting on the Recycling and Remanufacturing of High-end Medical Imaging Equipment

Conclusion Meeting on the Recycling and Remanufacturing of High-end Medical Imaging Equipment

Read more
2021-05-31 > Beijing

Comments to NMPA's Public Consultation on the Classification Rules for In Vitro Diagnostics

The medical devices sector sent comments to the National Medical Products Administration's public consultation on the Classification Rules for In Vitro Diagnostics.

Read more
2021-05-31 > Beijing

Comments to NMPA's Public Consultation on the In-Vitro Diagnostic Reagent Registration Application Data Requirements and Approval Document Format

The medical devices sector sent comments to the National Medical Products Administration's (NMPA) public consultation on the In-Vitro Diagnostic Reagent Registration Application Data Requirements and Approval Document Format.

Read more
2021-05-31 > Beijing

Comments to NMPA's Pulic Consultation on the Medical Device Registration Application Data Requirements and Approval Document Format

The medical devices sector sent comments to the National Medical Products Administration's (NMPA) public consultation on the Medical Device Registration Application Data Requirements and Approval Document Format.

Read more
2021-05-31 > Beijing

Comments to NMPA's Public Consultation on the Category of Medical Devices Exempeted from Clinical Evalutaion

The medical devices sector sent comments to the National Medical Products Administration's (NMPA) public consultation on the Category of Medical Devices Exempeted from Clinical Evalutaion.

Read more
2021-05-31 > Beijing

Comments to NMPA's Public Consultation on the Technical Guideline for Methodological Comparison Of In Vitro Diagnostic Reagents Free of Clinical Trials

The medical devices sent comments to the National Medical Products Administration's (NMPA) public consultation Technical Guideline for Methodological Comparison Of In Vitro Diagnostic Reagents Free of Clinical Trials.

Read more